| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4271557 | F | Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two-fold serial dilution method | Staphylococcus aureus | 8 | ALA4270515 | organism-based format | Scientific Literature | |
| 2. | ALA4271558 | F | Antimicrobial activity against Bacillus cereus UW 85 after 24 hrs by two-fold serial dilution method | Bacillus cereus | 8 | ALA4270515 | organism-based format | Scientific Literature | |
| 3. | ALA4271559 | F | Antimicrobial activity against Escherichia coli ATCC 12435 after 24 hrs by two-fold serial dilution method | Escherichia coli | 8 | ALA4270515 | organism-based format | Scientific Literature | |
| 4. | ALA4271560 | F | Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by two-fold serial dilution method | Pseudomonas aeruginosa | 9 | ALA4270515 | organism-based format | Scientific Literature | |
| 5. | ALA4271561 | F | Antimicrobial activity against Candida albicans after 48 hrs by two-fold serial dilution method | Candida albicans | 10 | ALA4270515 | organism-based format | Scientific Literature | |
| 6. | ALA4271562 | F | Antimicrobial activity against Aspergillus fumigatus 293 after 48 hrs by two-fold serial dilution method | Aspergillus fumigatus | 9 | ALA4270515 | organism-based format | Scientific Literature | |
| 7. | ALA4271563 | F | Antimicrobial activity against Aspergillus flavus 3375 after 48 hrs by two-fold serial dilution method | Aspergillus flavus | 9 | ALA4270515 | organism-based format | Scientific Literature | |
| 8. | ALA4271564 | B | Inhibition of N-acyl-homoserinlactone-related quorum sensing system in Chromobacterium violaceum ATCC 12472 assessed as diameter of violacein pigment inhibition after 48 hrs | Chromobacterium violaceum | 10 | ALA4270515 | assay format | Scientific Literature | |
| 9. | ALA4271565 | F | Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 48 hrs by MTT assay | Homo sapiens | 10 | ALA4270515 | cell-based format | Scientific Literature | |
| 10. | ALA4271566 | F | Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 48 hrs by MTT assay | Homo sapiens | 10 | ALA4270515 | cell-based format | Scientific Literature | |
| 11. | ALA4271567 | F | Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 48 hrs by MTT assay | Homo sapiens | 10 | ALA4270515 | cell-based format | Scientific Literature | |
| 12. | ALA4271568 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as mean survival time at 0.5 mg/mouse administered for 9 days (Rvb = 14.5 day) | Mus musculus | 5 | ALA4270515 | cell-based format | Scientific Literature | |
| 13. | ALA4271569 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as increase in life span at 0.5 mg/mouse administered for 9 days relative to control | Mus musculus | 5 | ALA4270515 | cell-based format | Scientific Literature | |
| 14. | ALA4271570 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as effect on tumor volume at 0.5 mg/mouse administered for 9 days (Rvb = 9.85 mL) | Mus musculus | 5 | ALA4270515 | cell-based format | Scientific Literature | |
| 15. | ALA4271571 | F | Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as effect on viable tumor cell count at 0.5 mg/mouse administered for 9 days by trypan blue staining based method (Rvb = 83.20 10'6/ml) | Mus musculus | 5 | ALA4270515 | cell-based format | Scientific Literature | |
| 16. | ALA4271572 | T | Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as effect on hemoglobin content at 0.5 mg/mouse administered for 9 days (Rvb = 8.15 g/dl) | Mus musculus | 5 | ALA4270515 | organism-based format | Scientific Literature | |
| 17. | ALA4271573 | T | Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as effect on RBC count at 0.5 mg/mouse administered for 9 days (Rvb = 3.69 10'6/mm3) | Mus musculus | 5 | ALA4270515 | organism-based format | Scientific Literature | |
| 18. | ALA4271574 | T | Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as effect on WBC count at 0.5 mg/mouse administered for 9 days (Rvb = 23.96 10'3/mm3) | Mus musculus | 5 | ALA4270515 | organism-based format | Scientific Literature | |
| 19. | ALA4271575 | A | Cytotoxicity against human W138 cells assessed as decrease in cell viability after 48 hrs by MTT assay | Homo sapiens | 5 | ALA4270515 | cell-based format | Scientific Literature | |
| 20. | ALA4271576 | A | Cytotoxicity against human WISH cells assessed as decrease in cell viability after 48 hrs by MTT assay | Homo sapiens | 5 | ALA4270515 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!